Research Topics
| R CapocacciaSummaryAffiliation: Istituto Superiore di Sanit Country: Italy Publications
| Collaborators
|
Detail Information
Publications
The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysisR Capocaccia
National Centre of Epidemiology, Istituto Superiore di Sanita, Rome, Italy
Ann Oncol 14:v14-27. 2003..Comparison of quality indicators for the EUROCARE-3 database with earlier EUROCARE databases indicates that data quality and standardisation have improved...
Measuring cancer prevalence in Europe: the EUROPREVAL projectR Capocaccia
Istituto Superiore di Sanita, Rome, Italy
Ann Oncol 13:831-9. 2002..Prevalence of cancer is estimated to be 2% on average, with the highest values (3%) in Sweden and the lowest in Eastern Europe, with a minimum of approximately 1% in Poland...
Incidence and prevalence of all cancerous diseases in Italy: trends and implicationsA Verdecchia
Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita, Viale Regina Elena, 299, 00161, Rome, Italy
Eur J Cancer 37:1149-57. 2001..These favourable trends contribute to the increase in healthy life expectation, thus supporting the idea that we live longer and healthier...
The cure for colon cancer: results from the EUROCARE studyA Verdecchia
Istituto Superiore di Sanita, Rome, Italy
Int J Cancer 77:322-9. 1998....
Estimating population-based incidence and prevalence of major coronary eventsS Giampaoli
Istituto Superiore di Sanita, Laboratory of Epidemiology and Biostatistics, Rome, Italy
Int J Epidemiol 30:S5-10. 2001..While mortality data are currently and exhaustively collected in all developed countries and in a few developing countries, incidence and prevalence are often available only for certain subgroups of the population under study...
The cure of cancer: a European perspectiveSilvia Francisci
Cancer Epidemiology Unit, National Center for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita, Rome, Italy
Eur J Cancer 45:1067-79. 2009..The proportion of cured of all cancers combined is a useful general indicator of cancer control as it reflects progress in diagnosis and treatment, as well as success in the prevention of rapidly fatal cancers...
Correcting the completeness bias of observed prevalenceI Corazziari
Epidemiology and Biostatistics Laboratory, Superior Institute of Health, Rome, Italy
Tumori 85:370-81. 1999..Furthermore, we give helpful suggestions to obtain approximate values of the correction factor to be used for ages and periods of observation that are intermediate between the ones presented in this paper...
Incidence, mortality and prevalence of stomach cancer in Italian regionsR De Angelis
Laboratorio di Epidemiologia e Biostatistica, , Rome, Italy
Tumori 82:314-20. 1996..About 45,000 prevalent cases were estimated in Italy by 1990, half of which have been diagnosed before 1984...
Electronic availability of EUROCARE-3 data: a tool for further analysisP Roazzi
Data Analysis Centre, Istituto Superiore di Sanita, Rome, Italy
Ann Oncol 14:v150-5. 2003..The EUROCARE-3 CD-ROM can be ordered free of charge or directly downloaded at http://www.eurocare.it...
Estimating relative survival of Italian cancer patients from sparse cancer registries dataR De Angelis
, Rome, Italy
Tumori 83:33-8. 1997..The national estimates of breast cancer survival pattern show a mild decrease of survival with age and a marked increase with period of diagnosis...
Estimating regional cancer burden in countries with partial registration coverage: an application to all malignant neoplasms in Italy over the period 1970-2010E Grande
Cancer Epidemiology Unit, National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita, Viale Regina Elena, 299, 00161 Rome, Italy
Eur J Cancer 42:3236-45. 2006..These estimates are useful for planning health services on a national and regional basis and for highlighting regional differences...
The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysisRoberta De Angelis
Centro Nazionale di Epidemiologia, Istituto Superiore di Sanita, Viale Regina Elena 299, Rome, Italy
Eur J Cancer 45:909-30. 2009..3% were censored alive after less than five years' follow-up. These indicators suggest satisfactory data quality that has improved since EUROCARE-3...
Survival trends in European cancer patients diagnosed from 1988 to 1999Arduino Verdecchia
National Centre of Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita, Roma, Italy
Eur J Cancer 45:1042-66. 2009..The marked survival improvements in countries with poor survival may indicate that these countries have made efforts to adopt the new diagnostic procedures and the standardised therapeutic protocols in use in more affluent countries...
An age and period reconstruction of the HIV epidemic in ItalyA Verdecchia
Laboratorio di Epidemiologia e Biostatistica, , Rome, Italy
Int J Epidemiol 23:1027-39. 1994..CONCLUSIONS. Using a hypothesis of no more HIV infections after 1990, AIDS counts would be still rising in Italy up to 1993 as a result of past infections and of the long incubation period...
Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidenceF Citarda
Regina Elena Cancer Institute, Rome, Italy
Gut 48:812-5. 2001....
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United StatesMilena Sant
Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133, Milan, Italy
Eur J Cancer 44:579-87. 2008..Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved...
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgeryL Ciccolallo
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian, 1, 20133 Milan, Italy
Gut 54:268-73. 2005..Population based colorectal cancer survival among patients diagnosed in 1985-89 was lower in Europe than in the USA (45% v 59% five year relative survival)...
Population-based incidence and mortality cancer trends (1986-1997) from the network of Italian cancer registriesE Crocetti
Registro Tumori Toscano, UO Epidemiologia Clinica e Descrittiva, CSPO, Via di San Salvi 12, 50135 Firenze, Italy
Eur J Cancer Prev 13:287-95. 2004..The Italian health care system will also have to cope with growing cancer diagnostic and therapeutic needs due to population ageing...
Survival in patients with uveal melanoma in EuropeGianni Virgili
Department of Oto Neuro Ophthalmological Surgical Sciences, University of Florence, Viale Morgagni 85, Florence 50134, Italy
Arch Ophthalmol 126:1413-8. 2008..To estimate survival in patients in whom uveal melanoma was diagnosed between January 1, 1983, and December 31, 1994, in Europe...
Colon cancer prevalence and estimation of differing care needs of colon cancer patientsG Gatta
Istituto Nazionale per lo Studio e la Cura dei Tumori, Epidemiology Unit, Milan
Ann Oncol 15:1136-42. 2004..We estimated the proportions of the prevalent colon cancer cases requiring initial care, terminal care and follow-up...
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentaryM Sant
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Ann Oncol 14:v61-118. 2003..The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes...
Life expectancy and cancer survival in the EUROCARE-3 cancer registry areasA Micheli
Unit of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Ann Oncol 14:v28-40. 2003..However, sufficiently detailed mortality data are not available for all areas covered by the cancer registries (CRs) participating in the EUROCARE-3 study...
Cancer survival in European adolescents and young adultsG Gatta
Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
Eur J Cancer 39:2600-10. 2003....
Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphologyG Gatta
Istituto Nazionale per lo Studio e la Cura dei Tumori, Division of Epidemiology, Via Venezian 1, 1 20133 Milan, Italy
Eur J Cancer 39:2214-22. 2003..The main explanatory difference is the proportion of adenocarcinoma in polyps...
Cancer prevalence in European registry areasA Micheli
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
Ann Oncol 13:840-65. 2002..Information on cancer prevalence is of major importance for health planning and resource allocation. However, systematic information on cancer prevalence is largely unavailable...
Survival for retinoblastoma in EuropeM Sant
Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I-20133, Milan, Italy
Eur J Cancer 37:730-5. 2001..There was statistically significant effect related to the period of diagnosis, with a 50% reduction in the relative risk (RR) for children diagnosed in 1986--1989 compared with those diagnosed in 1978-1981...
Estimated incidence and prevalence of female breast cancer in Italian regionsA Micheli
Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
Tumori 78:13-21. 1992..In 1987, about 250,000 Italian women had a present or past history of breast cancer: for the 1970-1987 period, prevalence has increased by approximately 5,500 cases per year...
The rise and fall in primary liver cancer mortality in ItalyL Capocaccia
Dig Liver Dis 34:606-7; author reply 607-8. 2002
